Stocks
Xilio Therapeutics, Inc.XLO
NASDAQHealthcareBiotechnology$8.13
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing tumor-selective immunotherapies designed to activate the immune system within the tumor microenvironment while minimizing systemic toxicity. Its lead candidates target solid tumors, and investors track the stock for its pipeline progress and clinical data readouts.
52W Range: $6.47-$12.59
Congressional Interest in Xilio Therapeutics, Inc. (XLO)
No congressional trades have been disclosed for Xilio Therapeutics, Inc. (XLO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading XLO?
No congressional trades found for this stock.